Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosis.
Rizzoli R, Greenspan SL, Bone G 3rd, Schnitzer TJ, Watts NB, Adami S, Foldes AJ, Roux C, Levine MA, Uebelhart B, Santora AC 2nd, Kaur A, Peverly CA, Orloff JJ; Alendronate Once-Weekly Study Group. Rizzoli R, et al. Among authors: greenspan sl. J Bone Miner Res. 2002 Nov;17(11):1988-96. doi: 10.1359/jbmr.2002.17.11.1988. J Bone Miner Res. 2002. PMID: 12412806 Free article. Clinical Trial.
Previous fractures at multiple sites increase the risk for subsequent fractures: the Global Longitudinal Study of Osteoporosis in Women.
Gehlbach S, Saag KG, Adachi JD, Hooven FH, Flahive J, Boonen S, Chapurlat RD, Compston JE, Cooper C, Díez-Perez A, Greenspan SL, LaCroix AZ, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Sambrook PN, Silverman S, Siris ES, Watts NB, Lindsay R. Gehlbach S, et al. Among authors: greenspan sl. J Bone Miner Res. 2012 Mar;27(3):645-53. doi: 10.1002/jbmr.1476. J Bone Miner Res. 2012. PMID: 22113888 Free PMC article.
Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW).
Díez-Pérez A, Adachi JD, Adami S, Anderson FA Jr, Boonen S, Chapurlat R, Compston JE, Cooper C, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, Nieves JW, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Wyman A, Rushton-Smith SK, Watts NB; Global Longitudinal Study of Osteoporosis in Women (GLOW) Investigators. Díez-Pérez A, et al. Among authors: greenspan sl. J Bone Miner Res. 2014 Jan;29(1):260-7. doi: 10.1002/jbmr.2023. J Bone Miner Res. 2014. PMID: 23794198 Free PMC article.
Increase in Fracture Risk Following Unintentional Weight Loss in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women.
Compston JE, Wyman A, FitzGerald G, Adachi JD, Chapurlat RD, Cooper C, Díez-Pérez A, Gehlbach SH, Greenspan SL, Hooven FH, LaCroix AZ, March L, Netelenbos JC, Nieves JW, Pfeilschifter J, Rossini M, Roux C, Saag KG, Siris ES, Silverman S, Watts NB, Anderson FA Jr. Compston JE, et al. Among authors: greenspan sl. J Bone Miner Res. 2016 Jul;31(7):1466-72. doi: 10.1002/jbmr.2810. J Bone Miner Res. 2016. PMID: 26861139 Free PMC article. Clinical Trial.
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.
Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, Felsenberg D, Recker RR, Tonino RP, Roux C, Pinchera A, Foldes AJ, Greenspan SL, Levine MA, Emkey R, Santora AC 2nd, Kaur A, Thompson DE, Yates J, Orloff JJ. Schnitzer T, et al. Among authors: greenspan sl. Aging (Milano). 2000 Feb;12(1):1-12. Aging (Milano). 2000. PMID: 10746426 Clinical Trial.
Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).
Díez-Pérez A, Hooven FH, Adachi JD, Adami S, Anderson FA, Boonen S, Chapurlat R, Compston JE, Cooper C, Delmas P, Greenspan SL, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Roux C, Saag KG, Sambrook P, Silverman S, Siris ES, Watts NB, Nika G, Gehlbach SH. Díez-Pérez A, et al. Among authors: greenspan sl. Bone. 2011 Sep;49(3):493-8. doi: 10.1016/j.bone.2011.05.007. Epub 2011 May 14. Bone. 2011. PMID: 21605715 Free PMC article.
Predictors of treatment with osteoporosis medications after recent fragility fractures in a multinational cohort of postmenopausal women.
Greenspan SL, Wyman A, Hooven FH, Adami S, Gehlbach S, Anderson FA Jr, Boone S, Lacroix AZ, Lindsay R, Netelenbos JC, Pfeilschifter J, Silverman S, Siris ES, Watts NB. Greenspan SL, et al. J Am Geriatr Soc. 2012 Mar;60(3):455-61. doi: 10.1111/j.1532-5415.2011.03854.x. Epub 2012 Feb 8. J Am Geriatr Soc. 2012. PMID: 22316070 Free PMC article.
Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW).
Compston JE, Flahive J, Hosmer DW, Watts NB, Siris ES, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Chapurlat RD, Boonen S, Anderson FA Jr, Adami S, Adachi JD; GLOW Investigators. Compston JE, et al. Among authors: greenspan sl. J Bone Miner Res. 2014 Feb;29(2):487-93. doi: 10.1002/jbmr.2051. J Bone Miner Res. 2014. PMID: 23873741 Free PMC article. Clinical Trial.
When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW).
Costa AG, Wyman A, Siris ES, Watts NB, Silverman S, Saag KG, Roux C, Rossini M, Pfeilschifter J, Nieves JW, Netelenbos JC, March L, LaCroix AZ, Hooven FH, Greenspan SL, Gehlbach SH, Díez-Pérez A, Cooper C, Compston JE, Chapurlat RD, Boonen S, Anderson FA Jr, Adachi JD, Adami S. Costa AG, et al. Among authors: greenspan sl. PLoS One. 2013 Dec 11;8(12):e83306. doi: 10.1371/journal.pone.0083306. eCollection 2013. PLoS One. 2013. PMID: 24349484 Free PMC article. Clinical Trial.
263 results